Table 4.

In patients who received at least one cycle of IV/IP chemotherapy (N=261), cited rationale for starting with IV-only chemotherapy or discontinuing IV/IP chemotherapy early

Cited Rationale	n (%)
IV-only chemotherapy started initially	40 (15%)
Delayed wound healing	12 (5%)
Infection	8 (3%)
Low KPS	6 (2%)
Avoid delay for IP port placement	5 (2%)
IP port malfunction	3 (1%)
Ileostomy	2 (1%)
Other	4 (1.5%)
IV/IP chemotherapy discontinued early	66 (25%)
Toxicity	44 (17%)
Fatigue	8 (3%)
Abdominal pain	5 (2%)
Nephrotoxicity	5 (2%)
Nausea	4 (1.5%)
Bowel obstruction	4 (1.5%)
Neuropathy	3 (1%)
Multiple	11 (4%)
Other	4 (1.5%)
IP port malfunction	6 (2%)
Patient request	4 (1.5%)
Not stated	3 (1%)
Progression of disease	2 (1%)
Other	7 (3%)